A 2014 FDA and European Medicines Agency (EMA) joint analysis found similar rates of pancreatic cancer between GLP-1-treated patients and comparators, though absolute event numbers were small
Our doctors will review your condition, explain the possibilities, and outline a personalized plan tailored to your needs
While these averages are useful as a broad comparison point, they dont paint the full picture
Bonuccelli GA, Negrini R, da Silva Ferreira RD (2022) Premature birth in women with endometriosis: a systematic review and meta-analysis
Currently, 13 states fully cover GLP-1s for obesity treatment under Medicaid, and legislative efforts continue to target expanded coverage
Every plan is customizedand every patient is supported with education, transparency, and follow-up care